Hamman, while one must do their own research...that's all I've been doing for the last 2 and a bit years.....
- Science
- Patients
- Company
...I still have plenty to do and read and of course learn....BUT while I personally do a stack of research, that doesn't mean we ARE going to be successful 100%. There is still risk.
But in all that time I have only come across scares/real possible negatives a handful of times and each and every time they have been quashed one way or the other (from what I ascertain).
If you ask me whether I think the results are good..well from the above bullet points, yes. I think they are. Go through any of my major posts and you will get a sense of why I think that.
In a nutshell what do we compare ourselves to?
Opioids - horrid, addictive, dangerous
NASAID - Terrible, can lead to major gut problems, liver problems and a raft of side effects
Corticosteroids? Terrible, can increase rate of joint failure, do not use these for prolonged period despite the allure of instant pain relief for a few weeks.
Stem Cells - Too new, need clinical trials to prove this and longitudinal studies to check...its hit and miss still, the tech will get better but its a way off. Quite expensive for the moment too.
Granted that for pain relief there isn't a lot one can do and do it safely, I feel sorry for those that have no choice.
Surgery eventually becomes the only option.
With some 75% getting at least 25% efficacy and circa 88% getting some pain relief, to do that safely are results beyond imagination if we get through P3 and there are no serious AE's.
Then there is DMOAD.
DYOR
- Forums
- ASX - By Stock
- PAR
- research reports and media
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.55%
!
42.0¢

research reports and media, page-3016
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
42.0¢ |
Change
-0.020(4.55%) |
Mkt cap ! $166.9M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 41.5¢ | $271.6K | 637.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5960 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 3696 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5960 | 0.420 |
4 | 71417 | 0.415 |
6 | 136146 | 0.410 |
2 | 40000 | 0.405 |
5 | 196500 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 3696 | 1 |
0.440 | 25000 | 1 |
0.445 | 17788 | 4 |
0.450 | 44500 | 2 |
0.460 | 25378 | 3 |
Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Iggy Tan, Executive Chairman
Iggy Tan
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online